Discover 1,918 paid clinical trials in Denton, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,918
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
for
Congenital Adrenal Hyperplasia,
Location: Dallas TX, Aurora CO, Atlanta GA, Rochester MN,
Sponsor: Crinetics Pharmaceuticals Inc.
Sex: All
Age: 18 - 70+
Code: NCT07144163
Phase3, Recruiting
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
for
Generalized Myasthenia Gravis
Location: Dallas TX, Houston TX, Columbia MO, Colorado Springs CO,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT04202341
Recruiting
Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects
for
Asthma
Location: Dallas TX, Austin TX, Bellevue NE, El Paso TX,
Sponsor: Biometry Inc
Sex: All
Age: 5 - 70+
Code: NCT07228026
Recruiting
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
for
Geographic Atrophy, Macular Degeneration
Location: Dallas TX, Willow Park TX, Austin TX, The Woodlands TX,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 60+
Code: NCT06635148
Phase2, Recruiting
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
Location: Dallas TX, Willow Park TX, Tyler TX, Austin TX,
Sponsor: 4D Molecular Therapeutics
Sex: All
Age: 50+
Code: NCT07064759
Phase3, Recruiting
An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene
Location: Dallas TX, Aurora CO, Atlanta GA, Madison WI,
Sponsor: Splice Bio
Sex: All
Age: 12 - 65
Code: NCT06435000
Recruiting
Patch-free Occlusion Therapy
for
Amblyopia
Location: Dallas TX
Sponsor: Retina Foundation of the Southwest
Sex: All
Age: 3 - 12
Code: NCT05440448
Recruiting
A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)
A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
for
Stargardt Disease, Stargardt Macular Dystrophy,
Location: Dallas TX, Southaven MS, Chicago IL, Cincinnati OH,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 6+
Code: NCT07425574
Recruiting
An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Dallas TX, Carmel IN, La Crosse WI, Reno NV
Sponsor: Complement Therapeutics
Sex: All
Age: 55+
Code: NCT07392255
Phase1, Phase2, Recruiting
Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
for
Geographic Atrophy (GA)
Location: Dallas TX, Austin TX, The Woodlands TX, Lakewood CO,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 50+
Code: NCT07230834
Phase1, Recruiting
A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)
for
Stargardt Disease
Location: Dallas TX, Bellaire TX, Rochester MN, Phoenix AZ,
Sponsor: AAVantgarde Bio Srl
Sex: All
Age: 8 - 55
Code: NCT07161544
Phase1, Phase2, Recruiting
Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)
for
ARB, BVMD, Autosomal-Dominant Bestrophinopathy,
Location: Dallas TX, Cincinnati OH, Los Angeles CA
Sponsor: Opus Genetics, Inc
Sex: All
Age: 18+
Code: NCT07185256
Phase1, Phase2, Recruiting
Improving Control of Intermittent Exotropia
for
Intermittent Exotropia
Location: Dallas TX
Sponsor: Retina Foundation of the Southwest
Sex: All
Age: 4 - 10
Code: NCT07272005
Recruiting
A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Dallas TX, Oak Forest IL, La Crosse WI, Durham NC,
Sponsor: Complement Therapeutics
Sex: All
Age: 55+
Code: NCT07144137
Recruiting
A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)